+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Medical Hyperspectral Imaging Systems Market Size, Share & Trends Analysis Report By Product (Hyperspectral Camera, and Accessories), By Technology (Snapshot, Push Broom, and Others), By Application, By End-use, By Country and Growth Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 126 Pages
  • April 2024
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5953695
The Europe Medical Hyperspectral Imaging Systems Market would witness market growth of 11.1% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Medical Hyperspectral Imaging Systems Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $414.3 Million by 2031. The UK market is exhibiting a CAGR of 10.1% during (2024 - 2031). Additionally, The France market would experience a CAGR of 12% during (2024 - 2031).



Hyperspectral imaging (HSI) technology has its roots in remote sensing and military applications, where it was used to analyze images captured by satellites or aircraft to identify objects or materials based on their spectral signatures. Recently, there has been a notable advancement in the medical application of this technology, providing practitioners with an effective instrument to diagnose and manage a wide range of ailments and conditions.

One key advantage of these imaging systems is their ability to capture detailed spectral information across various wavelengths. This allows for identifying subtle differences in tissue composition that may not be visible with traditional imaging techniques. For example, hyperspectral imaging can help differentiate between healthy and diseased tissues based on their spectral signatures in cancer diagnosis, potentially leading to earlier and more accurate detection.

The UK may invest more in research and development initiatives related to medical imaging technologies. This could lead to innovations in hyperspectral imaging systems tailored to the specific needs and preferences of the UK healthcare system. The Office for National Statistics estimates that the healthcare expenditure in the United Kingdom was £257.6 billion in 2020, or £3,840 per person. In 2020, the aggregate healthcare expenditure in the United Kingdom comprised 12.0% of the country's gross domestic product (GDP), up from 9.9% in 2019. Thus, the high healthcare expenditure in the region is driving the growth of the market.

Based on Product, the market is segmented into Hyperspectral Camera, and Accessories. Based on Technology, the market is segmented into Snapshot, Push Broom, and Others. Based on Application, the market is segmented into Medical Diagnostics, Quality Assurance & Drug Testing, and Others. Based on End-use, the market is segmented into Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research & Academic Institutes. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

  • Specim, Spectral Imaging Ltd. (Konica Minolta, Inc.)
  • XIMEA Group
  • ClydeHSI
  • Diaspective Vision GmbH
  • Cubert GmbH
  • HyperMed Imaging, Inc.
  • Headwall Photonics, Inc.
  • Resonon Inc.
  • BaySpec, Inc.
  • Imec VZW

Market Report Segmentation

By Product
  • Hyperspectral Camera
  • Accessories
By Technology
  • Snapshot
  • Push Broom
  • Others
By Application
  • Medical Diagnostics
  • Quality Assurance & Drug Testing
  • Others
By End Use
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutes
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Medical Hyperspectral Imaging Systems Market, by Product
1.4.2 Europe Medical Hyperspectral Imaging Systems Market, by Technology
1.4.3 Europe Medical Hyperspectral Imaging Systems Market, by Application
1.4.4 Europe Medical Hyperspectral Imaging Systems Market, by End-use
1.4.5 Europe Medical Hyperspectral Imaging Systems Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Europe Medical Hyperspectral Imaging Systems Market by Product
4.1 Europe Hyperspectral Camera Market by Country
4.2 Europe Accessories Market by Country
Chapter 5. Europe Medical Hyperspectral Imaging Systems Market by Technology
5.1 Europe Snapshot Market by Country
5.2 Europe Push Broom Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Medical Hyperspectral Imaging Systems Market by Application
6.1 Europe Medical Diagnostics Market by Country
6.2 Europe Quality Assurance & Drug Testing Market by Country
6.3 Europe Others Market by Country
Chapter 7. Europe Medical Hyperspectral Imaging Systems Market by End-use
7.1 Europe Hospitals & Clinics Market by Country
7.2 Europe Pharmaceutical & Biotechnology Companies Market by Country
7.3 Europe Research & Academic Institutes Market by Country
Chapter 8. Europe Medical Hyperspectral Imaging Systems Market by Country
8.1 Germany Medical Hyperspectral Imaging Systems Market
8.1.1 Germany Medical Hyperspectral Imaging Systems Market by Product
8.1.2 Germany Medical Hyperspectral Imaging Systems Market by Technology
8.1.3 Germany Medical Hyperspectral Imaging Systems Market by Application
8.1.4 Germany Medical Hyperspectral Imaging Systems Market by End-use
8.2 UK Medical Hyperspectral Imaging Systems Market
8.2.1 UK Medical Hyperspectral Imaging Systems Market by Product
8.2.2 UK Medical Hyperspectral Imaging Systems Market by Technology
8.2.3 UK Medical Hyperspectral Imaging Systems Market by Application
8.2.4 UK Medical Hyperspectral Imaging Systems Market by End-use
8.3 France Medical Hyperspectral Imaging Systems Market
8.3.1 France Medical Hyperspectral Imaging Systems Market by Product
8.3.2 France Medical Hyperspectral Imaging Systems Market by Technology
8.3.3 France Medical Hyperspectral Imaging Systems Market by Application
8.3.4 France Medical Hyperspectral Imaging Systems Market by End-use
8.4 Russia Medical Hyperspectral Imaging Systems Market
8.4.1 Russia Medical Hyperspectral Imaging Systems Market by Product
8.4.2 Russia Medical Hyperspectral Imaging Systems Market by Technology
8.4.3 Russia Medical Hyperspectral Imaging Systems Market by Application
8.4.4 Russia Medical Hyperspectral Imaging Systems Market by End-use
8.5 Spain Medical Hyperspectral Imaging Systems Market
8.5.1 Spain Medical Hyperspectral Imaging Systems Market by Product
8.5.2 Spain Medical Hyperspectral Imaging Systems Market by Technology
8.5.3 Spain Medical Hyperspectral Imaging Systems Market by Application
8.5.4 Spain Medical Hyperspectral Imaging Systems Market by End-use
8.6 Italy Medical Hyperspectral Imaging Systems Market
8.6.1 Italy Medical Hyperspectral Imaging Systems Market by Product
8.6.2 Italy Medical Hyperspectral Imaging Systems Market by Technology
8.6.3 Italy Medical Hyperspectral Imaging Systems Market by Application
8.6.4 Italy Medical Hyperspectral Imaging Systems Market by End-use
8.7 Rest of Europe Medical Hyperspectral Imaging Systems Market
8.7.1 Rest of Europe Medical Hyperspectral Imaging Systems Market by Product
8.7.2 Rest of Europe Medical Hyperspectral Imaging Systems Market by Technology
8.7.3 Rest of Europe Medical Hyperspectral Imaging Systems Market by Application
8.7.4 Rest of Europe Medical Hyperspectral Imaging Systems Market by End-use
Chapter 9. Company Profiles
9.1 Specim, Spectral Imaging Ltd. (Konica Minolta, Inc.)
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.6 SWOT Analysis
9.2 XIMEA Group
9.2.1 Company Overview
9.2.2 Recent strategies and developments:
9.2.2.1 Product Launches and Product Expansions:
9.2.3 SWOT Analysis
9.3 ClydeHSI
9.3.1 Company Overview
9.3.2 SWOT Analysis
9.4 Diaspective Vision GmbH
9.4.1 Company Overview
9.4.2 Recent strategies and developments:
9.4.2.1 Partnerships, Collaborations, and Agreements:
9.4.3 SWOT Analysis
9.5 Cubert GmbH
9.5.1 Company Overview
9.5.2 SWOT Analysis
9.6 HyperMed Imaging, Inc.
9.6.1 Company Overview
9.6.2 SWOT Analysis
9.7 Headwall Photonics, Inc.
9.7.1 Company Overview
9.7.2 Recent strategies and developments:
9.7.2.1 Partnerships, Collaborations, and Agreements:
9.7.2.2 Acquisition and Mergers:
9.7.3 SWOT Analysis
9.8 Resonon Inc.
9.8.1 Company Overview
9.9 BaySpec, Inc.
9.9.1 Company Overview
9.9.2 SWOT Analysis
9.10. Imec VZW
9.10.1 Company Overview
9.10.2 SWOT Analysis

Companies Mentioned

  • Specim, Spectral Imaging Ltd. (Konica Minolta, Inc.)
  • XIMEA Group
  • ClydeHSI
  • Diaspective Vision GmbH
  • Cubert GmbH
  • HyperMed Imaging, Inc.
  • Headwall Photonics, Inc.
  • Resonon Inc.
  • BaySpec, Inc.
  • Imec VZW

Methodology

Loading
LOADING...